This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
newExtra banner

Your questions answered

Questions you may have

My patient has been on injectable contraception for longer than two years, what should I do?
My patient has missed one or more appointments in the last year, what should I do?
Can Nexplanon offer my patients rapid reversal of the contraceptive effects?
When should NEXPLANON be inserted and does it start working immediately?
Where is my nearest complex/deep removal centre?
How can I order a placebo NEXPLANON device, NEXPLANON palpator or a NEXPLANON ruler and pen?
Is NEXPLANON effective in heavier women?
What bleeding patterns can women expect while on NEXPLANON?
My patient’s implant is no longer palpable. What should I do?
I would like to gain a qualification in fitting and removing implants. How do I do this?
Are there any side effects with NEXPLANON?

Questions your patients may have

Can I switch to the implant from another method of contraception?
How long does it take to insert the implant?
Will it hurt having the implant inserted?
How is the implant removed?
How long does it take to remove the implant?

More information about NEXPLANON® (etonogestrel):

NexConnect - Medical Information


  1. NEXPLANON Summary of Product Characteristics.
  2. DEPO PROVERA Summary of Product Characteristics.
  3. CEU guidance on Progestogen-only Injectable Contraception. Available at: Last accessed March 2017.
  4. Jeffreys LA, Clark AL. A successful approach to long-acting contraceptive implants in primary care. Contraception. 2012; 85(4):381-383.
  5. Agrawal A, Robinson C. An assessment of the first 3 years’ use of Implanon in Luton. J Fam Plann Preprod Health Care. 2005; 31(4):310-2.
  6. Rai K, et al. Experience with Implanon® in a north-east London family planning clinic. Eur J Contracept Reprod Health Care. 2004; 9(1):39-46.
  7. Lakha F, Glasier AF. Continuation rates of implanon in the UK: data from an observational study in a clinical setting. Contraception. 2006; 74(4):287-9.
  8. Makarainen L et al. Fertil Steril 1998;69:714–21. 5. Croxatto HB et al. Hum Reprod 1999;14:976– 81.
  9. Faculty of Sexual and Reproductive Healthcare Clinical Guidance, Progestogen-only implants. Clinical Effectiveness Unit. February 2014.
  10. Levine JP, Sinofsky FE, Christ MF; Implanon US Study Group. Assessment of Implanon insertion and removal. Contraception 2008; 78(5): 409–417.
  11. Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt H-J, Gemzell-Danielsson K. Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 2010; (82): 243–249.

Supporting documentation

Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

GB-XPL-00044 | Date of Preparation: March 2019